241
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma

, , , , , & show all
Pages 562-569 | Received 17 Jan 2014, Accepted 06 Feb 2014, Published online: 22 Jul 2014

References

  • Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341:173–181
  • Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008;25:168–173
  • Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy: when to worry, what to do. Arch Dermatol 2000;136:905–914
  • Fong J, Gole G, Sullivan T. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol 2010;38:547–553
  • Didi I, Ben-Zion I, Samuel C, et al. Reduction in astigmatism using propranolol as first line therapy for periocular capillary hemangioma. Am J Ophtalmol 2011;151:53–58
  • Price CJ, Lattouf C, Baum B, et al. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol 2011;147:1371–1376
  • Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003;48:477–493
  • Kelly ME, Juern AM, Grossman WJ, et al. Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas. Arch Dermatol 2010;146:767–774
  • Bonnin N, Nezzar H, Dubray C, et al. Plasma levels and systemic safety of 0.1% unpreserved timolol maleate gel, 0.5% timolol aqueous solution and 0.5% timolol maleate gel. J Fr Ophtalmol 2012;35:9–16
  • Inoue K, Setogawa A, Higa R, et al. Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs. Clin Ophthalmol 2012;6:231–235
  • Martindale. Timolol maleato. In Guia Completa de Consulta Farmacoterapéutica. 2nd ed. Barcelona: Pharma Editores; 2006:1273
  • The United States pharmacopeia, 34nd rev., and The national formulary, 29th ed. Rockville (MD): United States Pharmacopeial Convention; 2011:1133
  • Blatt J, Morrell DS, Buck S, et al. β-Blockers for infantile hemangiomas: a single-institution experience. Clin Pediatr (Phila) 2011;50:757–763
  • Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol 2010;128:255–256
  • Ni N, Langer P, Wagner R, et al. Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol 2011;129:377–379
  • Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649–2651
  • Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol 2012;29:28–31
  • Fernández-Ballesteros MD, Vera-Casaño A, Escudero-Gómez J, et al. Infantile hemangioma of the eyelid treated with timolol gel. Actas Dermo-Sifiliograficas 2012;103:444–446
  • Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010;146:564–565
  • Valenta C, Auner BG. The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm 2004;58:279–289
  • The United States pharmacopeia, 34nd rev., and The national formulary, 29th ed. Rockville (MD): United States Pharmacopeial Convention; 2011:4809–4810
  • ICH Harmonised Tripartite Guideline. Validation of analitical procedures: text and methodology Q2(R1). Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf [last accessed 7 Jan 2014]
  • Taylor MJ, Tanna S, Sahota TS, et al. Rheological characterisation of dextran-concavalin. A mixtures as a basis for a self-regulated drug delivery device. Eur J Pharm Biopharm 2006;62:94–100
  • Kampf N, Nussinovitch A. Rheological characterization of k-carragean soy milks gels. Food Hydrocolloid 1997;11:261–269
  • Ribeiro KO, Rodrigues MI, Sabadini E, et al. Mechanical properties of acid sodium caseinate-κ-carrageenan gels: effect of co-solute addition. Food Hydrocolloid 2004;18:71–79
  • Wium H, Qvist KB. Rheological properties of UF-feta cheese determined by uniaxial compression and dynamic testing. J Texture Stud 1997;28:435–454
  • Ferrari F, Beferoni M, Caramella C. Rheological and mechanical properties of pharmaceutical gels. Part I: non-medicated systems. Boll Chim Farma 2001;140:329–336
  • Torres LG, Iturbe R, Snowden MJ, et al. Preparation of o/w emulsions stabilized by solid particles and their characterization by oscillatory rheology. Colloid Surface A 2007;302:439–448
  • Alfaro MC, Guerrero AF, Muñoz J. Dynamic viscoelasticity and flow behaviour of a polyoxyethylene glicol nonylphenyl ether/toluene/water system. Langmuir 2000;16:4711–4719
  • Medina-Torres L, Brito-De La Fuente E, Torrestiana-Sanchez B, et al. Rheological properties of the mucilage gum (Opuntia ficus indica). Food Hydrocolloid 2000;14:417–424
  • Álvarez-Manceñido F, Braeckmans K, de Smedt SC, et al. Characterization of diffusion of macromolecules in konjac glucomannan solutions and gels by fluorescence recovery after photobleaching technique. Int J Pharmaceut 2006;316:37–46
  • Rudraraju VS, Wyandt ChM. Rheological characterization of microcrystalline cellulose/sodium carboxymethyl cellulose hydrogels using a controlled stress rheometer: part I. Int J Pharmaceut 2005; 292:53–61
  • Lucero MJ, Claro C, Casas M, et al. Rheological and mechanical properties of hydrophilic dispersions using a new hydrophobically modified polymer and Igepal® CO520. Carbohyd Polym 2011;86:891–896

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.